Differences in duration of Huntington's disease based on age at onset

被引:153
作者
Foroud, T [1 ]
Gray, J [1 ]
Ivashina, J [1 ]
Conneally, PM [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
关键词
Huntington's disease; duration; age at onset;
D O I
10.1136/jnnp.66.1.52
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives-Data from a sample of 2494 patients affected with Huntington's disease (HD), collected as part of the National Research Roster for Huntington Disease Patients and Families, were examined to determine if there was a relation between age at onset and duration of illness. Methods-Sufficient data for inclusion in analysis was available from 2068 patients, of whom 828 were deceased and 1240 were living. The median duration of disease was 21.4 years with a range of 1.2 to 40.8 years. Patients were categorised into one of four groups based on their age at onset. Results-Significant differences in duration based on the age at onset were found (p<0.025), with juvenile and late onset patients with HD having shorter duration of illness compared with those with an onset between 20-49 years. Conclusions-Duration of disease is influenced by the age at symptom onset with juvenile and late onset patients having the shortest duration.
引用
收藏
页码:52 / 56
页数:5
相关论文
共 23 条
[1]   Longitudinal change in basal ganglia volume in patients with Huntington's disease [J].
Aylward, EH ;
Li, Q ;
Stine, OC ;
Ranen, N ;
Sherr, M ;
Barta, PE ;
Bylsma, FW ;
Pearlson, GD ;
Ross, CA .
NEUROLOGY, 1997, 48 (02) :394-399
[2]   Trinucleotide repeat length and clinical progression in Huntington's disease [J].
Brandt, J ;
Bylsma, FW ;
Gross, R ;
Stine, OC ;
Ranen, N ;
Ross, CA .
NEUROLOGY, 1996, 46 (02) :527-531
[3]   PROGRESSION RATE AND AGE AT ONSET ARE RELATED IN AUTOSOMAL DOMINANT NEUROLOGIC DISEASES [J].
CURRIER, RD ;
JACKSON, JF ;
MEYDRECH, EF .
NEUROLOGY, 1982, 32 (08) :907-909
[4]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[5]   TRINUCLEOTIDE REPEAT LENGTH INSTABILITY AND AGE-OF-ONSET IN HUNTINGTONS-DISEASE [J].
DUYAO, M ;
AMBROSE, C ;
MYERS, R ;
NOVELLETTO, A ;
PERSICHETTI, F ;
FRONTALI, M ;
FOLSTEIN, S ;
ROSS, C ;
FRANZ, M ;
ABBOTT, M ;
GRAY, J ;
CONNEALLY, P ;
YOUNG, A ;
PENNEY, J ;
HOLLINGSWORTH, Z ;
SHOULSON, I ;
LAZZARINI, A ;
FALEK, A ;
KOROSHETZ, W ;
SAX, D ;
BIRD, E ;
VONSATTEL, J ;
BONILLA, E ;
ALVIR, J ;
CONDE, JB ;
CHA, JH ;
DURE, L ;
GOMEZ, F ;
RAMOS, M ;
SANCHEZRAMOS, J ;
SNODGRASS, S ;
DEYOUNG, M ;
WEXLER, N ;
MOSCOWITZ, C ;
PENCHASZADEH, G ;
MACFARLANE, H ;
ANDERSON, M ;
JENKINS, B ;
SRINIDHI, J ;
BARNES, G ;
GUSELLA, J ;
MACDONALD, M .
NATURE GENETICS, 1993, 4 (04) :387-392
[6]   FUNCTIONAL DECLINE IN HUNTINGTONS-DISEASE [J].
FEIGIN, A ;
KIEBURTZ, K ;
BORDWELL, K ;
COMO, P ;
STEINBERG, K ;
SOTACK, J ;
ZIMMERMAN, C ;
HICKEY, C ;
ORME, C ;
SHOULSON, I .
MOVEMENT DISORDERS, 1995, 10 (02) :211-214
[7]  
Folstein SE, 1989, HUNTINGTONS DIS DISO
[8]   Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease [J].
Furtado, S ;
Suchowersky, O ;
Rewcasle, NB ;
Graham, L ;
Klimek, ML ;
Garber, A .
ANNALS OF NEUROLOGY, 1996, 39 (01) :132-136
[9]  
HARPER PS, 1991, MAJOR PROBLEMS NEURO, V22
[10]   TRINUCLEOTIDE REPEAT LENGTH AND RATE OF PROGRESSION OF HUNTINGTONS-DISEASE [J].
ILLARIOSHKIN, SN ;
IGARASHI, S ;
ONODERA, O ;
MARKOVA, ED ;
NIKOLSKAYA, NN ;
TANAKA, H ;
CHABRASHWILI, TZ ;
INSAROVA, NG ;
ENDO, K ;
IVANOVASMOLENSKAYA, IA ;
TSUJI, S .
ANNALS OF NEUROLOGY, 1994, 36 (04) :630-635